Variables associated with the platelet count 6 weeks after autologous peripheral blood progenitor cell transplantation

Bone Marrow Transplantation

Volumn 22, Issue 6, 1998, Pages 547-551

  Bolwell, B ^a   Goormastic, M ^a   Andresen, S ^a   Koo, A ^a   Wise, K ^a   Overmoyer, B ^a   Pohlman, B ^a   Kalaycio, M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Autologous progenitor cell transplant; Platelet engraftment; Stem cells

Indexed keywords

ANTINEOPLASTIC AGENT; CD34 ANTIGEN; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGE; ARTICLE; BREAST CANCER; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; LEUKAPHERESIS; LEUKEMIA; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEGAKARYOCYTE; MULTIVARIATE ANALYSIS; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

EID: 0031695618     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701378     Document Type: Article

References (23)

1. + cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1997; 19: 303-310.
2. Marks LB, Rosner GL, Prosnitz LR et al. The impact of conventional plus high dose chemotherapy with autologous bone marrow transplantation on hematologic toxicity during subsequent local-regional radiotherapy for breast cancer. Cancer 1994; 74: 2964-2971.
3. Marks LB, Halperin EC, Prosnitz LR et al. Post-mastectomy radiotherapy following adjuvant chemotherapy and autologous bone marrow transplantation for breast cancer patients with ≥10 positive axillary lymph notes. Int J Radiat Oncol Biol Phys 1992; 23: 1021-1026.
4. Bolwell BJ, Goormastic M, Andresen S et al. Platelet transfusion requirements during autologous peripheral blood progenitor cell transplantation correlate with the pretransplant platelet count. Bone Marrow Transplant 1997; 20: 459-463.
5. + cell yield. Blood 1997; 90 (Suppl. 1): 332b (Abstr. 4202).
6. Reiffers J, Faberes C, Boiron JM et al. Peripheral blood progenitor cell transplantation in 118 patients with hematological malignancies: analysis of factors affecting the rate of engraftment. J Hematother 1994; 3: 185-191.
7. Siena S, Bregni M, Brando B et al. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 1991; 77: 440-409.
8. Bolwell BJ, Goormastic M, Yanssens T et al. Comparison of G-CSF with GM-CSF for mobilizing peripheral blood progenitor cells and for enhancing marrow recovery after autologous bone marrow transplant. Bone Marrow Transplant 1994; 14: 913-918.
9. Bensinger W, Appelbaum F, Rowley S et al. Factors that influence collection and engraftment of autologous peripheral blood stem cells. J Clin Oncol 1995; 13: 2547-2555.
10. + content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995; 86: 3961-3969.
11. Moskowitz CH, Stiff P, Gordon MS et al. Recombinant methionyl human stem cell factor and filgrastim for peripheral blood progenitor cell mobilization and transplantation in non-Hodgkin's lymphoma patients - results of a phase I/II trial. Blood 1997; 89: 3136-3147.
12. Glaspy JA, Shpall EJ, LeMaistre CF et al. Peripheral blood progenitor cell mobilization using stem cell factors in combingation with filgrastim in breast cancer patients. Blood 1997; 90: 2939-2951.
13. Sudo Y, Shimazaki C, Ashihara E et al. Synergistic effect of FLT-3 ligand on the granulocyte colony-stimulating factor - induced mobilization of hematopoietic stem cells and progenitor cells into blood in mice. Blood 1997; 89: 3186-3191.
14. Bolwell B, Vredenburgh J, Overmoyer B et al. Safety and biologic effect of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in breast cancer patients following autologous peripheral blood progenitor cell transplantation (PBPC). Blood 1997; 89 (Suppl. 1): 171a (Abstr. 756).
15. Haas R, Witt B, Möhle R et al. Sustained long-term hematopoiesis after myeloablative therapy with peripheral blood progenitor cell support. Blood 1995; 85: 3754-3761.
16. Bentley SA, Brecher ME, Powell E et al. Long-term engraftment failure after marrow ablation and autologous hematopoietic reconstitution: differences between peripheral blood stem cell and bone marrow recipients. Bone Marrow Transplant 1997; 19: 557-563.
17. To LB, Roberts MM, Haylock DN et al. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 1992; 9: 277-284.
18. Brice P, Divine M, Marolleau JP et al. Comparison of autografting using mobilized peripheral blood stem cells with and without granulocyte colony-stimulating factor in malignant lymphomas. Bone Marrow Transplant 1994; 14: 51-55.
19. Colombat Ph, Delain M, Desbois I et al. Granulocyte-macro-phage colony-stimulating factor accelerates hematopoietic recovery after autologous bone marrow or peripheral blood progenitor cell transplantation and high-dose chemotherapy for lymphoma. Bone Marrow Transplant 1996; 18: 293-299.
20. Molineux G, Hartley C, McElroy P et al. Megakaryocyte growth and development factor accelerates platelet recovery in peripheral blood progenitor cell transplant recipients. Blood 1996; 88: 366-376.
21. Kabaya K, Shibuya K, Torri Y et al. Improvement of thrombocytopenia following bone marrow transplantation by pegylated recombinant human megakaryocyte growth and development factor in mice. Bone Marrow Transplant 1996; 18: 1035-1041.
22. O'Malley CJ, Rasko JEJ, Basser RL et al. Administration of pegylated recombinant human megakaryocyte growth and development factor to humans stimulates the production of functional platelets that show no evidence of in vivo acti- vation, Blood 1996; 88: 3288-3298.
23. Siena S, Bregni M, Dinicola M et al. Durability of hematopoiesis following autografting with peripheral blood hematopoietic progenitors. Ann Oncol 1994; 5: 935-941.